Medicina
Departamento
Hospital Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Carlos III (101)
2021
-
Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation
BMC Cardiovascular Disorders, Vol. 21, Núm. 1
2020
-
Imported cysticercosis in Spain: A retrospective case series from the +REDIVI Collaborative Network
Travel Medicine and Infectious Disease, Vol. 37
-
Latent and active tuberculosis infections in migrants and travellers: A retrospective analysis from the Spanish +REDIVI collaborative network
Travel Medicine and Infectious Disease, Vol. 36
2019
-
A new variant (c.1A>G)in LDLRAP1 causing autosomal recessive hypercholesterolemia: Characterization of the defect and response to PCSK9 inhibition
Atherosclerosis, Vol. 284, pp. 223-229
-
Clinicoepidemiological characteristics of viral hepatitis in migrants and travellers of the +Redivi network
Travel Medicine and Infectious Disease, Vol. 29, pp. 51-57
-
Functional analysis of new variants at the low-density lipoprotein receptor associated with familial hypercholesterolemia
Human Mutation, Vol. 40, Núm. 8, pp. 1181-1190
-
Standards for global cardiovascular risk management arteriosclerosis
Clinica e Investigacion en Arteriosclerosis, Vol. 31, pp. 1-43
2018
-
COSMIC project: Consensus on the objectives of the metabolic syndrome in clinic
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol. 11, pp. 683-697
-
Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study
Open Forum Infectious Diseases, Vol. 5, Núm. 1
2017
-
Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach
PLoS ONE, Vol. 12, Núm. 9
-
Prevalence of peripheral artery disease (PAD) and factors associated: An epidemiological analysis from the population-based Screening PRE-diabetes and type 2 DIAbetes (SPREDIA-2) study
PLoS ONE, Vol. 12, Núm. 10
2016
-
Fármacos hipolipemiantes y PCSK9
Clinica e Investigacion en Arteriosclerosis, Vol. 28, pp. 9-13
-
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013
Journal of Infection, Vol. 72, Núm. 5, pp. 587-596
-
MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression
PLoS ONE, Vol. 11, Núm. 5
-
Short communication: p21/CDKN1A expression shows broad interindividual diversity in a subset of HIV-1 elite controllers
AIDS Research and Human Retroviruses, Vol. 32, Núm. 3, pp. 232-236
2015
-
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
PLoS Medicine, Vol. 12, Núm. 3
-
Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities
European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 1, pp. 46-54
-
Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis
Nature Communications, Vol. 6
-
Normal reference values of left ventricular strain using three-dimensional speckle tracking echocardiography: Results from amulticentre study
European Heart Journal Cardiovascular Imaging, Vol. 16, Núm. 4, pp. 410-416
-
Novedades cardiovasculares 2013/2014
Revista Clinica Espanola, Vol. 215, Núm. 1, pp. 33-42